Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry
Cisplatin is a commonly used chemotherapeutic drug in cancer treatment, whereas Gd@C 82 (OH) 22 is a new nanomaterial anti-tumor agent. In this study, we determined intracellular Gd@C 82 (OH) 22 and cisplatin after treatment of Hela and 16HBE cells by single cell inductively coupled plasma-mass spec...
Saved in:
Published in | Analytical and bioanalytical chemistry Vol. 407; no. 9; pp. 2383 - 2391 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.03.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cisplatin is a commonly used chemotherapeutic drug in cancer treatment, whereas Gd@C
82
(OH)
22
is a new nanomaterial anti-tumor agent. In this study, we determined intracellular Gd@C
82
(OH)
22
and cisplatin after treatment of Hela and 16HBE cells by single cell inductively coupled plasma-mass spectrometry (SC-ICP-MS), which could provide quantitative information at a single-cell level. The cell digestion method validated the accuracy of the SC-ICP-MS. The concentrations of Gd@C
82
(OH)
22
and cisplatin in cells at different exposure times and doses were studied. The SC-ICP-MS is a promising complement to available methods for single cell analysis and is anticipated to be applied further to biomedical research.
Graphical Abstract
The quantitative results of Gd@C
82
(OH)
22
in single cells determined by SC-ICP-MS and acid digestion method, respectively |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1618-2642 1618-2650 |
DOI: | 10.1007/s00216-014-8422-3 |